Venous thromboembolism in multiple myeloma is associated with increased mortality.

ABSTRACT:

Background

In multiple myeloma, venous thromboembolism (VTE) is common, and treatments for myeloma, such as lenalidomide, increase the risk of thrombosis while improving survival. The association between VTE and survival is not well known.

Objectives

To determine the association between VTE and survival in multiple myeloma (MM) while adjusting for known confounders that affect risk of thrombosis and survival, including patient characteristics and treatment in a retrospective cohort of US veterans.

Patients/methods

A cohort of patients with newly diagnosed MM treated within Veterans Health Administration between September 1, 1999, and June 30, 2014, was created to assess the association between VTE and mortality using Cox proportional hazards regression modeling while

SUBMITTER: Schoen MW 

PROVIDER: S-EPMC7590313 | biostudies-literature | 2020 Oct

REPOSITORIES: biostudies-literature